Sign In
Buy NVCN
$30.03
+0 (+0%)
At Close: Jul 07, 2023
Shockwave Medical, Inc. Completes Acquisition of Neovasc
08:20am, Tuesday, 11'th Apr 2023
SANTA CLARA, CA, April 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Shockwave Medical, Inc. (NASDAQ: SWAV) (“Shockwave”), a pioneer in the development of Intravascular Lithotripsy (IVL) to tr
Shockwave Medical Completes Acquisition of Neovasc
07:59am, Tuesday, 11'th Apr 2023
SANTA CLARA, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV) (“Shockwave”), a pioneer in the development of Intravascular Lithotripsy (“IVL”) to treat severel
Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update
04:11pm, Friday, 31'st Mar 2023
VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today reported financial results for the fo
Neovasc Shareholders Approve Acquisition by Shockwave Medical
06:00pm, Monday, 06'th Mar 2023
Vancouver, British Columbia--(Newsfile Corp. - March 6, 2023) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive devices for the
A Bull Market Is Coming: 1 Outstanding Growth Stock Down 36% to Buy and Hold
05:39am, Wednesday, 22'nd Feb 2023
This up-and-coming medical technology star is set up to deliver market-beating gains for its long-term investors.
Neovasc Announces German Reimbursement Renewal
09:05am, Wednesday, 01'st Feb 2023
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 1, 2023) - Neovasc, Inc. (NASDAQ : NVCN) (TSX : NVCN) ("Neovasc" or "the Company") today announced the German Institu
Mergers and Acquisitions in 2023 Off To A Strong Start
08:17am, Friday, 27'th Jan 2023
Mergers and acquisitions are a normal part of business, but 2023 has already presented many opportunities across the biotech industry. The M&A surge seems to be driven by two major transactions: the $
Shockwave Medical To Buy Neovasc: Details (NVCN)
09:33am, Wednesday, 18'th Jan 2023
Neovasc announced that it is being acquired by Shockwave Medical. These are the details.
Shockwave Medical to Acquire Neovasc
08:27am, Tuesday, 17'th Jan 2023
Vancouver, British Columbia--(Newsfile Corp. - January 17, 2023) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company"), a leader in the development of minimally invasive devices for t
Neovasc (NVCN) is on the Move, Here's Why the Trend Could be Sustainable
10:32am, Wednesday, 11'th Jan 2023
Neovasc (NVCN) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Recent Price Trend in Neovasc (NVCN) is Your Friend, Here's Why
10:32am, Monday, 26'th Dec 2022
Neovasc (NVCN) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our
Neovasc Announces Progress on COSIRA-II Clinical Trial
05:00pm, Monday, 28'th Nov 2022
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - November 28, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced an update on the CO
Neovasc Comments on European Heart Journal Publication
09:05am, Friday, 18'th Nov 2022
VANCOUVER and MINNEAPOLIS, Nov. 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that European Heart Journal - Ca
Neovasc (NVCN) Reports Q3 Loss, Misses Revenue Estimates
09:49pm, Thursday, 10'th Nov 2022
Neovasc (NVCN) delivered earnings and revenue surprises of -6.38% and 7.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Neovasc Inc. (NVCN) Q3 2022 Earnings Call Transcript
08:03pm, Thursday, 10'th Nov 2022
Neovasc Inc. (NASDAQ:NVCN ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Mike Cavanaugh - Investor Relations Fred Colen - President & Chief Executive Officer Chri
